Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio.
Vidal-Alabró A, Colom H, Fontova P, Cerezo G, Melilli E, Montero N, Coloma A, Manonelles A, Favà A, Cruzado JM, Torras J, Grinyó JM, Lloberas N. Vidal-Alabró A, et al. Among authors: torras j. Nefrologia (Engl Ed). 2024 Mar-Apr;44(2):204-216. doi: 10.1016/j.nefroe.2024.03.019. Epub 2024 Apr 12. Nefrologia (Engl Ed). 2024. PMID: 38614890 Free article.
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
Lloberas N, Grinyó JM, Colom H, Vidal-Alabró A, Fontova P, Rigo-Bonnin R, Padró A, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Meneghini M, Favà A, Torras J, Cruzado JM. Lloberas N, et al. Among authors: torras j. Kidney Int. 2023 Oct;104(4):840-850. doi: 10.1016/j.kint.2023.06.021. Epub 2023 Jun 28. Kidney Int. 2023. PMID: 37391040 Clinical Trial.
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations.
Fontova P, van Merendonk LN, Vidal-Alabró A, Rigo-Bonnin R, Cerezo G, van Oevelen S, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Torras J, Cruzado JM, Grinyó JM, Colom H, Lloberas N. Fontova P, et al. Among authors: torras j. Pharmaceutics. 2023 May 12;15(5):1481. doi: 10.3390/pharmaceutics15051481. Pharmaceutics. 2023. PMID: 37242723 Free PMC article.
Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population Approach.
Lalagkas PN, Iliou J, Rigo R, Miarons M, Fernández-Alarcon B, Bestard O, Cruzado JM, Melilli E, Torras J, Grinyó JM, Lloberas N, Colom H. Lalagkas PN, et al. Among authors: torras j. Clin Pharmacokinet. 2023 Jun;62(6):861-880. doi: 10.1007/s40262-023-01237-3. Epub 2023 May 4. Clin Pharmacokinet. 2023. PMID: 37140726 Free PMC article.
Combining neutrophil and macrophage biomarkers to detect active disease in ANCA vasculitis: a combinatory model of calprotectin and urine CD163.
Anton-Pampols P, Martínez Valenzuela L, Fernández Lorente L, Quero Ramos M, Gómez Preciado F, Martín Capón I, Morandeira F, Manrique Escola J, Fulladosa X, Cruzado JM, Torras J, Draibe J. Anton-Pampols P, et al. Among authors: torras j. Clin Kidney J. 2022 Dec 7;16(4):693-700. doi: 10.1093/ckj/sfac257. eCollection 2023 Apr. Clin Kidney J. 2022. PMID: 37007690 Free PMC article.
Characteristics and Management of Ocular Involvement in Individuals with Monkeypox Disease.
Pazos M, Riera J, Moll-Udina A, Catala A, Narvaez S, Fuertes I, Dotti-Boada M, Petiti G, Izquierdo-Serra J, Maldonado E, Chang-Sotomayor M, Garcia D, Camós-Carreras A, Gilera V, De Loredo N, Peraza-Nieves J, Ventura-Abreu N, Spencer F, Del Carlo GF, Torras J, Nicolas JM, Adán A, Vilella A, Puig S, Martinez E, Martinez MJ, Sánchez-Dalmau B, Blanco JL. Pazos M, et al. Among authors: torras j. Ophthalmology. 2023 Jun;130(6):655-658. doi: 10.1016/j.ophtha.2023.02.013. Epub 2023 Feb 16. Ophthalmology. 2023. PMID: 36804274 Free PMC article. No abstract available.
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy.
Goicoechea M, Gomez-Preciado F, Benito S, Torras J, Torra R, Huerta A, Restrepo A, Ugalde J, Astudillo DE, Agraz I, Lopez-Mendoza M, de Arriba G, Corchete E, Quiroga B, Gutierrez MJ, Martin-Conde ML, Lopes V, Ramos C, Mendez I, Cao M, Dominguez F, Ortiz A; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Goicoechea M, et al. Among authors: torras j. Nefrologia (Engl Ed). 2021 Nov-Dec;41(6):652-660. doi: 10.1016/j.nefroe.2022.01.003. Nefrologia (Engl Ed). 2021. PMID: 36165155 Free article.
403 results